Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Altaire Pharmaceuticals Recalls Nine Lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution Sold Under Several Brands

By Pharmaceutical Processing | September 9, 2013

 

Altaire Pharmaceuticals is voluntarily recalling a total of nine lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution,  30 mL, to the consumer level. There have been no reports of adverse effects to consumers so far.  However, due to complaints of mold found in the 30 mL bottles after use, concerns regarding the effectiveness of the preservative after use and handling of the product by consumers have prompted the recall.

A product whose preservative is not effective could lead to use of a contaminated product which could be calamitous for any population since there is a reasonable probability of a potentially sight threatening eye infection.  It has been confirmed by Altaire that all lots of product were sterile at the time of release, and that the preservative was effective when challenged against the USP Preservative Effectiveness Test.  It has also been confirmed by Altaire that its production facility is not the source of any reported contaminants.

The product is known generically as Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution and labeled as follows:

— equate Restore Tears Lubricant Eye Drops Carboxymethylcellulose Sodium 0.5%, Sterile, 1 FL OZ (30 mL) – Distributed by Wal-Mart Stores, Inc.;

— Lubricant EYE DROPS FOR MILD TO MODERATE DRY EYE, STERILE, 1 FL OZ

(30 mL), for Mild to Moderate Dry Eye – Distributed by CVS Pharmacy, Inc.;

— lubricant eye drops for mild to moderate dry eye, STERILE, 1 FL OZ

(30 mL) –  Dist. by Target Corp.

Only the lots listed below are affected, and the recall is limited to the product in the 30 mL size:

— Lot # 11440, expiration date  09/2013, labeled for CVS;

— Lot # 11441, expiration date  09/2013, labeled for CVS;

— Lot # 12042, expiration date 01/2014, labeled for Wal-Mart and CVS;

— Lot # 12103, expiration date 02/2015, labeled for Wal-Mart;

— Lot # 12203, expiration date 05/2015, labeled for Wal-Mart and CVS;

— Lot # 12207, expiration date 05/2015, labeled for Wal-Mart;

— Lot # 12293, expiration date 08/2015, labeled for Wal-Mart;

— Lot # 12352, expiration date 09/2015, labeled for Target and CVS;

— Lot # 12356, expiration date 09/2015, labeled for Target and CVS.

Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution is a non-prescription (OTC) drug product used to relieve dryness of the eye and packaged in a plastic bottle inside a unit box.  Lot numbers can be found printed horizontally on the side of the label and on the bottom flap of the box.   The lots listed above were distributed between February 2012 and April 2013.   The product was sold nationwide at retail stores.

Altaire Pharmaceuticals is initiating the recall as a precautionary measure.  Altaire takes its mission of consumer care and providing quality products very seriously.  The company has reformulated the product with an enhanced preservative system.  All lots of the product in the 30 mL size identified with lot numbers beginning with 13 (i.e.

13000) have been made with the enhanced preservative system.

Altaire Pharmaceuticalsis notifying its customers of the recall by phone and letters for further notification to their retail stores.

Consumers who have the product with any of the lot numbers listed above should stop use of the product immediately and return it to the place of purchase.

Consumers with questions regarding this recall can contact Altaire Pharmaceuticals at 1-800-258-2471, Monday – Friday from 9 am – 5 pm ET.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

— Online:www.fda.gov/medwatch/report.htm — Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.

— Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE